Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 39, Issue 5, Pages 440-451Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2018.02.006
Keywords
-
Categories
Funding
- Engineering and Physical Sciences Research Council (EPSRC), UK [EP/L01646X]
Ask authors/readers for more resources
3D printing (3DP) is forecast to be a highly revolutionary technology within the pharmaceutical sector. In particular, the main benefits of 3DP lie in the production of small batches of medicines, each with tailored dosages, shapes, sizes and release characteristics. The manufacture of medicines in this way may finally lead to the concept of personalised medicines becoming a reality. In the shorter term, 3DP could be extended throughout the drug development process, ranging from preclinical development and clinical trials, through to frontline medical care. In this review, we provide a timely perspective on the motivations and potential applications of 3DP pharmaceuticals, as well as a practical viewpoint on how 3DP could be integrated across the pharmaceutical space.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available